Audit and Inspection Readiness for Archived Studies and Legacy Data
Audit and Inspection Readiness for Archived Studies and Legacy Data Audit and Inspection Readiness for Archived Studies and Legacy Data The increasing emphasis on data integrity and compliance in clinical trials mandates that organizations prioritize audit and inspection readiness, especially regarding archived studies and legacy data. Both the FDA and EMA have outlined stringent requirements…
Read More “Audit and Inspection Readiness for Archived Studies and Legacy Data” »